1. Home
  2. BFLY vs NVCR Comparison

BFLY vs NVCR Comparison

Compare BFLY & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

HOLD

Current Price

$4.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$15.24

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFLY
NVCR
Founded
2011
2000
Country
United States
Switzerland
Employees
220
N/A
Industry
Medical Electronics
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
BFLY
NVCR
Price
$4.68
$15.24
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$5.00
$28.08
AVG Volume (30 Days)
5.0M
1.2M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
$24.01
$7.72
Revenue Next Year
$19.93
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$1.32
$9.82
52 Week High
$5.72
$20.05

Technical Indicators

Market Signals
Indicator
BFLY
NVCR
Relative Strength Index (RSI) 50.14 69.77
Support Level $3.71 $12.66
Resistance Level $5.00 $15.09
Average True Range (ATR) 0.37 0.71
MACD -0.05 0.22
Stochastic Oscillator 40.30 89.93

Price Performance

Historical Comparison
BFLY
NVCR

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: